Skip to main content
Blackhawk Growth Corp. logo

Blackhawk Growth Corp. — Investor Relations & Filings

Ticker · BLR ISIN · CA09238B3083 LEI · 875500A5R3SVGXL39M70 CSE Financial and insurance activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2021-10-08 Regulatory Filings
Country CA Canada
Listing CSE BLR

About Blackhawk Growth Corp.

https://www.blackhawkgrowthcorp.com/

Blackhawk Growth Corp. operates as an investment issuer, specializing in generating shareholder value through strategic investments in the technology and life sciences sectors. The company focuses on acquiring and developing assets, intellectual property, and projects related to medical technologies, pharmaceuticals, digital health, software, big data, and AI. Blackhawk seeks opportunities that demonstrate global scalability and potential for positive impact on health and human wellbeing. Its core strategy involves providing capital for R&D and commercialization, followed by value realization through mergers, acquisitions, divestments, or spin-outs and public listings on North American stock exchanges.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2021-10-08 English
Material change report - English.pdf
Regulatory Filings
2021-10-04 English
News release - English.pdf
Regulatory Filings
2021-10-04 English
Material change report - English.pdf
Regulatory Filings Classification · 100% confidence The document is titled 'FORM 51-102F3 Material Change Report' and details a material change involving a collaboration agreement between Blackhawk Growth Corp.'s subsidiary and another company. It includes specific items such as the date of the material change, a summary, full description, and contact information for an executive officer. The form number 51-102F3 is a regulatory filing used in Canadian securities regulation to disclose material changes. The content is a formal announcement of a material change rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-09-29 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a collaboration agreement between Blackhawk Growth's subsidiary MindBio Therapeutics and Digital Mind Technology. It focuses on the business development and partnership details rather than financial results, regulatory filings, or shareholder information. There are no financial statements, earnings data, or regulatory compliance content. The document is a corporate announcement about a strategic collaboration, which does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is not a report publication announcement since it does not mention any report being published or attached. The content aligns best with a general corporate announcement about business activities, which falls under Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2021-09-29 English
Material change report - English.pdf
Regulatory Filings
2021-09-23 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.